HOW WE HELP
BioClaritas works with life science companies and investors at moments where business decisions have an outsized impact on future outcomes - from Discovery to IND, IND to Phase 2, Clinical Scale-up, or Commercial Readiness.
Engagements range from targeted strategic projects and advisory assignments to fractional leadership roles and finance team augmentation.
Supporting capital allocation, forecasting, scenario planning, portfolio analysis, board reporting, and long-range planning for leadership teams navigating complex decisions.
Providing experienced finance leadership during periods of growth, transition, financing activity, organizational change, or resource constraints - without the cost of a full-time executive.
Supporting CFOs and Heads of FP&A with additional capacity, specialized expertise, strategic analyses, and complex planning initiatives.
Supporting Discovery to IND, clinical development scale-up, commercial readiness, and organizational planning.
Supporting prioritization, resource allocation, strategic alternatives, licensing evaluations, partnership assessments, corporate strategy reviews, and enterprise value creation initiatives.
Improving capital efficiency through strategic sourcing, vendor & spend optimization, spend analytics, CRO & CDMO optimization, and operating leverage improvements.
Supporting diligence, portfolio company reviews, value creation planning, and strategic assessments.

A focused 2–4 week assessment designed to evaluate critical business decisions through the lens of capital, strategy, and execution.
Deliverables typically include:
• Capital allocation assessment
• Strategic priorities review
• Operational bottleneck analysis
• Risk and tradeoff evaluation
• Executive and board-ready recommendations

Supporting organizations preparing for a financing, extending runway, or evaluating capital alternatives.
Focus areas may include:
• Financing readiness
• Runway optimization
• Scenario modeling
• Capital structure evaluation
• Strategic capital planning

Helping organizations prepare for IND submission, early clinical execution, and organizational scale-up.
Focus areas may include:
• Development forecasting
• Clinical cost planning
• Vendor strategy
• Governance frameworks
• Resource planning

Supporting executive teams and boards facing difficult prioritization and capital allocation decisions.
Focus areas may include:
• Portfolio optimization
• Resource allocation
• Strategic alternatives
• Licensing evaluations
• Partnership economics

A focused review of organizational spend, vendor strategy, and operating leverage opportunities.
Focus areas may include:
• CRO and CDMO optimization
• Vendor rationalization
• Contract strategy
• Spend analytics
• Cost structure improvement

Designing planning, forecasting, reporting, and decision-support capabilities that enable organizations to scale effectively.
Focus areas may include:
• Long-range planning
• Forecasting frameworks
• KPI architecture
• Board reporting systems
• Scenario planning capabilities

Ongoing strategic support for executives, boards, investors, and leadership teams.

Focused support around a specific challenge, transaction, initiative, or inflection point.

Fractional CFO, strategic finance, and FP&A leadership support.

Flexible support for CFOs, Heads of FP&A, and finance organizations requiring additional capacity, expertise, or project leadership.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.